Independent Director · TG THERAPEUTICS, INC. (TGTX)

Daniel Hume — TG THERAPEUTICS Director Compensation (2025)

Fiscal year 2025 director compensation for Daniel Hume at TG THERAPEUTICS, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 30, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

TG THERAPEUTICS Director Compensation Table · the one fiscal year held
In US dollars, as TG THERAPEUTICS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$96,750$550,012$0$0$646,762

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TG THERAPEUTICS, INC. DEF 14A filed April 30, 2026, accession 0001437749-26-014233, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

TG THERAPEUTICS pays directors a $70,000 cash retainer and $550,000 in equity.

Committees

FY2025 · as the proxy prints them

Audit · Compensation · Nominating/Governance

The rest of the TG THERAPEUTICS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Kenneth HobermanIndependent Director$651,012
Laurence N. CharneyLead Independent Director$943,017
Michael S. WeissChair of the Board$0
Sagar Lonial, MDIndependent Director$644,262
Yann EchelardIndependent Director$646,762

The full TG THERAPEUTICS compensation record

free company brief

This page is one director within TG THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy